KBU2046 - CAS 1143863-69-7

KBU2046 is an orally administered compound that inhibits cell motility and invasion, effectively suppressing cancer metastasis and extending lifespan. This compound uniquely targets and binds to chaperone heterocomplexes, selectively modifying the interaction of client proteins involved in motility regulation, while avoiding the characteristics typical of classical HSP90 inhibitors.

Others, HSP

Cytoskeletal Signaling, Metabolism, Others

1143787

0.9989

C15H11FO2

242.24

Fc1ccc(cc1)C1COc2ccccc2C1=O

-20°C

Ice Packs

Small Compound